Company
Every investor coverage indicates participated in a round Magnis Energy Technologies raised.
Companies Magnis Energy Technologies acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| James Dack | Executive Director | @AuManufacturing |
| Frank Houllis | Chief Executive Officer (former) | RenewEconomy |
| Frank Poullas | Chairman | RenewEconomy |
Stories naming Magnis Energy Technologies. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Manufacturing briefs roundup: Magnis and Charge CCCV report encouraging battery cell test results, Nova Eye starts United States testing of its glaucoma catheter, and Noxopharm collects a government research rebate.
News briefs covering four manufacturers: Magnis banks $34m for a US battery factory, Bionomics locks in $16m, Noxopharm touts a prostate cancer drug pairing, and SciDev notches its maiden profit.
Also @AuManufacturing
Two manufacturers announced equity raisings: welding firm K-TIG secured $5.6 million via placement, while battery developer Magnis raised $7.65 million to advance proposed gigafactories in Townsville and New York.
ASX-listed battery maker Magnis entered a trading halt pending a planned capital raise, after a June raising and a Queensland government grant to its consortium for a Townsville gigafactory feasibility study; its CEO has departed.
Energy Renaissance wins federal co-funding for local battery production while Magnis Energy Technologies announces new development partners, with its partner CV4 securing New York State and BAE Systems support for transit batteries.
Magnis Energy reports partner C4V tested an EV battery cell charging to 85% in six minutes; production could occur at Magnis's planned Townsville gigafactory, which received $3.1 million in Queensland government grants.